2a4z
Crystal Structure of human PI3Kgamma complexed with AS604850
|
OverviewOverview
Phosphoinositide 3-kinases (PI3K) have long been considered promising drug, targets for the treatment of inflammatory and autoimmune disorders as well, as cancer and cardiovascular diseases. But the lack of specificity, isoform selectivity and poor biopharmaceutical profile of PI3K inhibitors, have so far hampered rigorous disease-relevant target validation. Here we, describe the identification and development of specific, selective and, orally active small-molecule inhibitors of PI3Kgamma (encoded by Pik3cg)., We show that Pik3cg(-/-) mice are largely protected in mouse models of, rheumatoid arthritis; this protection correlates with defective neutrophil, migration, further validating PI3Kgamma as a therapeutic target. We also, describe that oral treatment with a PI3Kgamma inhibitor suppresses the, progression of joint inflammation and damage in two distinct mouse models, of rheumatoid arthritis, reproducing the protective effects shown by, Pik3cg(-/-) mice. Our results identify selective PI3Kgamma inhibitors as, potential therapeutic molecules for the treatment of chronic inflammatory, disorders such as rheumatoid arthritis.
About this StructureAbout this Structure
2A4Z is a Single protein structure of sequence from Homo sapiens with BYM as ligand. Active as Phosphatidylinositol-4,5-bisphosphate 3-kinase, with EC number 2.7.1.153 Full crystallographic information is available from OCA.
ReferenceReference
Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis., Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, Chabert C, Gillieron C, Francon B, Martin T, Gretener D, Perrin D, Leroy D, Vitte PA, Hirsch E, Wymann MP, Cirillo R, Schwarz MK, Rommel C, Nat Med. 2005 Sep;11(9):936-43. Epub 2005 Aug 28. PMID:16127437
Page seeded by OCA on Mon Nov 12 20:46:20 2007